Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomized, double-blind, placebo-controlled, parallel group, multicenter study to assess the efficacy and safety of repeated treatment with tegaserod 6mg bid and placebo in women with irritable bowel syndrome with constipation (IBS-C)
tegaserod
CHTF919A2306
Not available
Irritable Bowel Syndrome with constipation (IBS-C)
Phase 3
 
September 2016

Powered by ideaPoint, Inc.